Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEPATOXALI
NCT06649474Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Sep 2024
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Serum HMGB1 concentrations. Started Sep 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06649474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06649474.